Rosacea

Latest News

National Rosacea Society Awards 2023 Grants for Research
National Rosacea Society Awards 2023 Grants for Research

November 9th 2023

Grants allow investigators to uncover the potential causes and key aspects of rosacea to pave the way for improved treatment, prevention, and possibly a cure.

Review Finds Topical Erythromycin, Azithromycin, and Metronidazole Most Common Treatments for Pediatric Rosacea
Review Finds Topical Erythromycin, Azithromycin, and Metronidazole Most Common Treatments for Pediatric Rosacea

November 2nd 2023

Julie Harper, MD, to Present a Rosacea Research Roundup and Pearls
Julie Harper, MD, to Present a Rosacea Research Roundup and Pearls

September 27th 2023

Oral Macrolides Demonstrate Efficacy in Aseptic Facial Granuloma
Oral Macrolides Demonstrate Efficacy in Aseptic Facial Granuloma

September 8th 2023

In Rosacea, Botulinum Toxin Requires Further Analysis of Long-Term Clinical Efficacy and Safety
In Rosacea, Botulinum Toxin Requires Further Analysis of Long-Term Clinical Efficacy and Safety

August 23rd 2023

Latest CME Events & Activities

Patient, Provider, and Caregiver Connection™: Incorporating the Patient Journey into HS Diagnosis and Management Practices

View More

Cases and Conversations™: Enhancing Diagnosis and Evaluation of Generalized Pustular Psoriasis in Advanced Practice Settings

View More

Clinical ShowCase™ in Atopic Dermatitis: Personalized Management Plans for Pediatric Patients

View More

Multidisciplinary Management of BPDCN: Strategies for Differential Diagnosis and Integrating Novel Targeted Therapy

View More

20th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®

View More

Facing the Changing Landscape for Neuromodulators and Dermal Fillers

View More

Advances In: Integrating New Treatment Options into Management Plans for Patients with Moderate-to-Severe Atopic Dermatitis

View More

Medical Crossfire®: Maximizing Patient Outcomes in Shingles – Are You Leveraging Guideline Based Care?

View More

"REEL" Time Patient Counseling™: Integrating Biosimilars into the Clinical Conversation

View More

PER Skin Summit: Optimizing Diagnosis and Individualizing Management of Hidradenitis Suppurativa

View More

Community Practice Connections™: 19th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®

View More

Expert Illustrations & Commentaries™: A Deeper Look at the Pathogenesis of Hidradenitis Suppurativa (HS)

View More

More News

© 2023 MJH Life Sciences

All rights reserved.